Runda Medical(SH:603108) Xin Lang Cai Jing·2025-10-31 05:36Group 1 - The core point of the news is that RunDa Medical's stock price increased by 5.18% to 16.66 CNY per share, with a trading volume of 411 million CNY and a turnover rate of 4.20%, resulting in a total market capitalization of 10.057 billion CNY [1] - RunDa Medical, established on January 6, 1999, and listed on May 27, 2015, is located in Shanghai and primarily provides in vitro diagnostic products and professional technical support to various medical laboratories through its comprehensive service system [1] - The company's main revenue sources are: reagents and other consumables (93.50%), instruments (3.70%), software development and services (2.67%), and others (0.14%) [1] Group 2 - From the perspective of major fund holdings, Nord Fund has a significant position in RunDa Medical, with the Nord Quantitative Blue Chip A fund holding 109,300 shares, accounting for 4.43% of the fund's net value, making it the third-largest holding [2] - The Nord Quantitative Blue Chip A fund, established on December 29, 2017, has a current scale of 860,900 CNY and has achieved a year-to-date return of 10.31%, ranking 5862 out of 8154 in its category [2] - The fund has a one-year return of 13.77%, ranking 5228 out of 8046, and a cumulative return since inception of 18.45% [2]